Cargando…

Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets

Bone is one of the most preferential target site for cancer metastases, particularly for prostate, breast, kidney, lung and thyroid primary tumours. Indeed, numerous chemical signals and growth factors produced by the bone microenvironment constitute factors promoting cancer cell invasion and aggres...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmid-Alliana, Annie, Schmid-Antomarchi, Heidy, Al-Sahlanee, Rasha, Lagadec, Patricia, Scimeca, Jean-Claude, Verron, Elise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796097/
https://www.ncbi.nlm.nih.gov/pubmed/29300334
http://dx.doi.org/10.3390/ijms19010148
_version_ 1783297432240521216
author Schmid-Alliana, Annie
Schmid-Antomarchi, Heidy
Al-Sahlanee, Rasha
Lagadec, Patricia
Scimeca, Jean-Claude
Verron, Elise
author_facet Schmid-Alliana, Annie
Schmid-Antomarchi, Heidy
Al-Sahlanee, Rasha
Lagadec, Patricia
Scimeca, Jean-Claude
Verron, Elise
author_sort Schmid-Alliana, Annie
collection PubMed
description Bone is one of the most preferential target site for cancer metastases, particularly for prostate, breast, kidney, lung and thyroid primary tumours. Indeed, numerous chemical signals and growth factors produced by the bone microenvironment constitute factors promoting cancer cell invasion and aggression. After reviewing the different theories proposed to provide mechanism for metastatic progression, we report on the gene expression profile of bone-seeking cancer cells. We also discuss the cross-talk between the bone microenvironment and invading cells, which impacts on the tumour actions on surrounding bone tissue. Lastly, we detail therapies for bone metastases. Due to poor prognosis for patients, the strategies mainly aim at reducing the impact of skeletal-related events on patients’ quality of life. However, recent advances have led to a better understanding of molecular mechanisms underlying bone metastases progression, and therefore of novel therapeutic targets.
format Online
Article
Text
id pubmed-5796097
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57960972018-02-09 Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets Schmid-Alliana, Annie Schmid-Antomarchi, Heidy Al-Sahlanee, Rasha Lagadec, Patricia Scimeca, Jean-Claude Verron, Elise Int J Mol Sci Review Bone is one of the most preferential target site for cancer metastases, particularly for prostate, breast, kidney, lung and thyroid primary tumours. Indeed, numerous chemical signals and growth factors produced by the bone microenvironment constitute factors promoting cancer cell invasion and aggression. After reviewing the different theories proposed to provide mechanism for metastatic progression, we report on the gene expression profile of bone-seeking cancer cells. We also discuss the cross-talk between the bone microenvironment and invading cells, which impacts on the tumour actions on surrounding bone tissue. Lastly, we detail therapies for bone metastases. Due to poor prognosis for patients, the strategies mainly aim at reducing the impact of skeletal-related events on patients’ quality of life. However, recent advances have led to a better understanding of molecular mechanisms underlying bone metastases progression, and therefore of novel therapeutic targets. MDPI 2018-01-04 /pmc/articles/PMC5796097/ /pubmed/29300334 http://dx.doi.org/10.3390/ijms19010148 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Schmid-Alliana, Annie
Schmid-Antomarchi, Heidy
Al-Sahlanee, Rasha
Lagadec, Patricia
Scimeca, Jean-Claude
Verron, Elise
Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
title Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
title_full Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
title_fullStr Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
title_full_unstemmed Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
title_short Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
title_sort understanding the progression of bone metastases to identify novel therapeutic targets
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796097/
https://www.ncbi.nlm.nih.gov/pubmed/29300334
http://dx.doi.org/10.3390/ijms19010148
work_keys_str_mv AT schmidallianaannie understandingtheprogressionofbonemetastasestoidentifynoveltherapeutictargets
AT schmidantomarchiheidy understandingtheprogressionofbonemetastasestoidentifynoveltherapeutictargets
AT alsahlaneerasha understandingtheprogressionofbonemetastasestoidentifynoveltherapeutictargets
AT lagadecpatricia understandingtheprogressionofbonemetastasestoidentifynoveltherapeutictargets
AT scimecajeanclaude understandingtheprogressionofbonemetastasestoidentifynoveltherapeutictargets
AT verronelise understandingtheprogressionofbonemetastasestoidentifynoveltherapeutictargets